[Problem of vascular reactivity in the mechanism of regulatory and pharmacological effects on the blood circulation].
D000470:Alkaloids / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D008725:Bis-Trimethylammonium Compounds / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents / Q000494:pharmacology; D014666:Vasomotor System / Q000502:physiology*; D014667:Vasopressins / Q000494:pharmacology
D000470:Alkaloids; D000959:Antihypertensive Agents; D008725:Bis-Trimethylammonium Compounds; D002395:Catecholamines; D005730:Ganglionic Blockers; D011941:Receptors, Adrenergic; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D000804:Angiotensin II; D000628:Aminophylline; D012701:Serotonin; D002110:Caffeine; D001285:Atropine; D012110:Reserpine; D004809:Ephedrine; D001920:Bradykinin; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine
Problema reaktivnosti sosudov v mekhanizme reguliatornykh i farmakologicheskikh vliianiĭ krovotok.